Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Andreas Reiter
Assistant Professor, MD
GermanyResearch Interests
Explore related searches
Articles (4)
Year:
2026
Year:
2025
Within the World Health Organization (WHO) classification of haematopoietic neoplasms, particularly its fifth version from 2022 (WHO-HAEM5), myeloid neoplasms are not only grouped into myeloproliferative (MPN) and myelodysplastic neoplasms (MDS). There is also a group of haematological disorders that share features of both categories termed myelodysplastic /myeloproliferative neoplasms (MDS/MPN). In this article, we aim to provide a comprehensive and practical guide to WHO-HAEM5 highlighting the genetic alterations that underlie MPN and MDS/MPN. This guide provides an overview of the overlapping commonalities among these entities, as well as their unique characteristics.
Year:
2024
Year:
2024
Collaborators (8)
Vikas Gupta
-
Nicholas Cross
Professor of Human Genetics
University of Southampton
Bethan Psaila
University of Oxford
Juan Carlos Hernandez-Boluda
Associate Professor
University of Valencia
Francesca Palandri
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Florian Heidel
Professor, Director and Chair
Hannover Medical School
David Ross
Flinders University School of Medicine
Timothy Devos
Professor (deeltijds hoogleraar)
KU Leuven
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.